Biotech, especially gene editing, comes to mind as a fast developing field. However, because it's health related, extensive testing and regulations means it will never evolve at the same pace as hardware and software did.
Biotech, especially gene editing, comes to mind as a fast developing field. However, because it's health related, extensive testing and regulations means it will never evolve at the same pace as hardware and software did.
The one silver lining of this catastrophe of covid is that the FDA process has been turned up to 11. There is some hope that it'll stay that way after/if a vaccine is made. The ModeRNA vaccine is looking to be some amazing stuff and it would have taken at least a decade to get through before covid.
CRISPR-CAS9 technology and a faster FDA should result in some very good outcomes for all humans. The biotech centers of San Diego, Boston, NC Research Triangle, and Denver should see growth from that kind of a boom.